SE0302035D0 - New compound - Google Patents

New compound

Info

Publication number
SE0302035D0
SE0302035D0 SE0302035A SE0302035A SE0302035D0 SE 0302035 D0 SE0302035 D0 SE 0302035D0 SE 0302035 A SE0302035 A SE 0302035A SE 0302035 A SE0302035 A SE 0302035A SE 0302035 D0 SE0302035 D0 SE 0302035D0
Authority
SE
Sweden
Prior art keywords
sup
new compound
treatment
compound
synthase
Prior art date
Application number
SE0302035A
Other languages
English (en)
Inventor
Benjamin Pelcman
Kristofer Olofsson
Martins Katkevics
Vita Ozola
Edgars Suna
Ivars Kalvins
Original Assignee
Biolipox Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolipox Ab filed Critical Biolipox Ab
Priority to SE0302035A priority Critical patent/SE0302035D0/sv
Publication of SE0302035D0 publication Critical patent/SE0302035D0/sv
Priority to EP04743337A priority patent/EP1646624A1/en
Priority to CA002528626A priority patent/CA2528626A1/en
Priority to JP2006518373A priority patent/JP2007516203A/ja
Priority to PCT/GB2004/002996 priority patent/WO2005005415A1/en
Priority to US10/563,464 priority patent/US20060160879A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
SE0302035A 2003-07-09 2003-07-09 New compound SE0302035D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0302035A SE0302035D0 (sv) 2003-07-09 2003-07-09 New compound
EP04743337A EP1646624A1 (en) 2003-07-09 2004-07-09 Indoles useful in the treatment of inflammation
CA002528626A CA2528626A1 (en) 2003-07-09 2004-07-09 Indoles useful in the treatment of inflammation
JP2006518373A JP2007516203A (ja) 2003-07-09 2004-07-09 炎症の治療に有用なインドール類
PCT/GB2004/002996 WO2005005415A1 (en) 2003-07-09 2004-07-09 Indoles useful in the treatment of inflammation
US10/563,464 US20060160879A1 (en) 2003-07-09 2004-07-09 Indoles useful in the treatment of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302035A SE0302035D0 (sv) 2003-07-09 2003-07-09 New compound

Publications (1)

Publication Number Publication Date
SE0302035D0 true SE0302035D0 (sv) 2003-07-09

Family

ID=27764958

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302035A SE0302035D0 (sv) 2003-07-09 2003-07-09 New compound

Country Status (2)

Country Link
US (1) US20060160879A1 (sv)
SE (1) SE0302035D0 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146616A1 (en) * 2004-06-18 2008-06-19 Kristofer Olofsson Indoles Useful in the Treatment of Inflammation
CA2594777A1 (en) * 2005-01-19 2006-07-27 Biolipox Ab Indoles useful in the treatment of inflamation
DE602005026867D1 (de) * 2005-01-19 2011-04-21 Biolipox Ab Entzündungshemmende indol-derivate
PT2134685E (pt) 2007-04-16 2015-11-25 Abbvie Inc Derivados de índole não substituídos na posição 7 como inibidores de mcl-1
EP3243814B1 (en) * 2007-04-16 2018-10-17 AbbVie Inc. 7-substituted indole as mcl-1 inhibitors
AU2010237302A1 (en) * 2009-04-14 2011-12-01 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
CN102659663A (zh) * 2012-04-06 2012-09-12 上海应用技术学院 一种5－氯－3－苯基吲哚－2－羰基酸乙酯的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
TW229140B (sv) * 1992-06-05 1994-09-01 Shell Internat Res Schappej B V
EP0763035A4 (en) * 1994-06-09 1997-10-01 Smithkline Beecham Corp ENDOTHELIN RECEPTOR ANTAGONISTS
US6630496B1 (en) * 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
CZ298827B6 (cs) * 1997-12-24 2008-02-20 Sanofi - Aventis Deutschland GmbH Deriváty indolu jako inhibitory faktoru Xa, zpusob jejich prípravy a farmaceutická kompozice, kteráje obsahuje
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) * 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) * 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
KR20030036917A (ko) * 2000-10-10 2003-05-09 스미스클라인 비참 코포레이션 치환된 인돌, 이를 함유하는 약제학적 조성물, 및 이의ＰＰＡＲ-γ결합제로서의 용도
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors

Also Published As

Publication number Publication date
US20060160879A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
IL179607A0 (en) Indoles useful in the treatment of inflammation
IL179728A0 (en) Indoles useful in the treatment of inflammation
TW200637820A (en) Indoles useful in the treatment of inflammation
TW200637818A (en) Indoles useful in the treatment of inflammation
TW200637819A (en) Indoles useful in the treatment of inflammation
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
WO2005005415A8 (en) Indoles useful in the treatment of inflammation
DE60335359D1 (de) Phthalazinonderivate
ATE359271T1 (de) Phenylderivate
PA8509301A1 (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en enfermedades inflamatorias, autoinmunes y respiratorias
GB9801690D0 (en) Therapeutic agents
TW200732320A (en) Pyrazoles useful in the treatment of inflammation
HK1087040A1 (en) Compounds for the treatment of metabolic disorders
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
SE0301232D0 (sv) Novel use
EA200801107A1 (ru) Пиразолы, пригодные для лечения воспалений
DK1531672T3 (da) Antimikrobielle sammensætninger
CY1109085T1 (el) Νεα αλατα
ATE368643T1 (de) Faktor xa benzamidin inhibitoren
SE0104250D0 (sv) Heterocyclic compounds
DE602005014233D1 (de) Zur behandlung von entzündungen geeignete indole
SE0203303D0 (sv) Novel Compounds
NO20052994L (no) Nye fosforamidderivater.
SE0100326D0 (sv) New compounds
SE0203070D0 (en) Novel compounds